Klein R, Klein B E, Moss S E, Cruickshanks K J
Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, USA.
Ophthalmology. 1998 Oct;105(10):1801-15. doi: 10.1016/S0161-6420(98)91020-X.
To examine the 14-year incidence and progression of diabetic retinopathy and macular edema and its relation to various risk factors.
Population-based incidence study.
The study was conducted in an 11-county area in southern Wisconsin.
Six hundred thirty-four insulin-taking persons with diabetes diagnosed before age 30 years participated in baseline, 4-year, 10-year, and 14-year follow-up examinations.
The 14-year progression of retinopathy, progression to proliferative retinopathy, and incidence of macular edema were detected by masked grading of stereoscopic color fundus photographs using the modified Airlie House classification and the Early Treatment Diabetic Retinopathy Study retinopathy severity scheme.
The 14-year rate of progression of retinopathy was 86%, regression of retinopathy was 17%, progression to proliferative retinopathy was 37%, and incidence of macular edema was 26%. Progression of retinopathy was more likely with less severe retinopathy, being male, having higher glycosylated hemoglobin or diastolic blood pressure at baseline, an increase in the glycosylated hemoglobin level, and an increase in diastolic blood pressure level from the baseline to the 4-year follow-up. Increased risk of proliferative retinopathy or incidence of macular edema was associated with more severe baseline retinopathy, higher glycosylated hemoglobin at baseline, and an increase in the glycosylated hemoglobin between the baseline and 4-year follow-up examination. The increased risk of proliferative retinopathy was associated with the presence of hypertension at baseline, whereas the increased risk of a participant having macular edema develop was associated with the presence of gross proteinuria at baseline. Lower glycosylated hemoglobin at baseline was associated with improvement in retinopathy.
These data suggest relatively high 14-year rates of progression of retinopathy and incidence of macular edema. These data also suggest that a reduction of hyperglycemia and hypertension may result in a beneficial decrease in the progression to proliferative retinopathy.
研究糖尿病视网膜病变和黄斑水肿的14年发病率、进展情况及其与各种危险因素的关系。
基于人群的发病率研究。
研究在威斯康星州南部的一个11县地区进行。
634名30岁之前被诊断为糖尿病且正在接受胰岛素治疗的患者参加了基线、4年、10年和14年的随访检查。
使用改良的艾利屋分类法和早期治疗糖尿病视网膜病变研究的视网膜病变严重程度方案,通过对立体彩色眼底照片进行盲法分级,检测视网膜病变的14年进展情况、进展为增殖性视网膜病变的情况以及黄斑水肿的发病率。
视网膜病变的14年进展率为86%,视网膜病变消退率为17%,进展为增殖性视网膜病变的比例为37%,黄斑水肿的发病率为26%。视网膜病变较轻、男性、基线时糖化血红蛋白或舒张压较高、糖化血红蛋白水平升高以及从基线到4年随访时舒张压水平升高的患者,视网膜病变进展的可能性更大。增殖性视网膜病变风险增加或黄斑水肿发病率增加与基线时视网膜病变更严重、基线时糖化血红蛋白水平较高以及基线和4年随访检查之间糖化血红蛋白增加有关。增殖性视网膜病变风险增加与基线时存在高血压有关,而黄斑水肿发生风险增加与基线时存在大量蛋白尿有关。基线时糖化血红蛋白水平较低与视网膜病变改善有关。
这些数据表明视网膜病变的14年进展率和黄斑水肿的发病率相对较高。这些数据还表明,降低高血糖和高血压可能有助于减少进展为增殖性视网膜病变。